Expression of ADAM29 and FAM135B in the pathological evolution from normal esophageal epithelium to esophageal cancer: Their differences and clinical significance

Wang,Tingting; Lv,Xiaoyan; Jiang,Shen; Han,Shaorong; Wang,Yanming

doi:10.3892/ol.2020.11272

Expression of ADAM29 and FAM135B in the pathological evolution from normal esophageal epithelium to esophageal cancer: Their differences and clinical significance

Authors:
- Tingting Wang
- Xiaoyan Lv
- Shen Jiang
- Shaorong Han
- Yanming Wang
View Affiliations

Affiliations: Department of Radiation Oncology, PLA 960th Hospital, Jinan, Shandong 250031, P.R. China, Department of Emergency Internal Medicine, Shanghai East Hospital, Tongji University School of Medicine, Shanghai 201203, P.R. China
Published online on: January 9, 2020 https://doi.org/10.3892/ol.2020.11272
Pages: 1727-1734
Copyright: © Wang et al. This is an open access article distributed under the terms of Creative Commons Attribution License.

Metrics: Total Views: 0 (Spandidos Publications: | PMC Statistics: )

Metrics: Total PDF Downloads: 0 (Spandidos Publications: | PMC Statistics: )

Cited By (CrossRef): 0 citations Loading Articles...

Abstract

A Disintegrin And Metalloprotease Domain 29 (ADAM29) and Family with sequence similarity 135 member B (FAM135B) genes have been reported to be associated with a carcinogenic risk of esophageal squamous cell carcinoma (ESCC). However, to the best of our knowledge, the expression of ADAM29 and FAM135B in the pathological evolution from normal esophageal epithelial cells to ESCC has not yet been investigated. The present study aimed to investigate the expression of ADAM29 and FAM135B in normal esophageal mucosal epithelium, low‑grade and high‑grade esophageal intraepithelial neoplasia, and ESCC. Furthermore, the present study aimed to investigate the role of ADAM29 and FAM135B in the development of esophageal lesions. Immunohistochemistry was performed in order to detect the expression levels of ADAM29 and FAM135B proteins in normal esophageal mucosa samples (40 cases), low‑grade intraepithelial neoplasia samples (20 cases), high‑grade intraepithelial neoplasia samples (20 cases) and ESCC samples (40 cases). The results of the present study demonstrated that the positive rates of ADAM29 and FAM135B proteins increased gradually from normal esophageal mucosal epithelium and esophageal intraepithelial neoplasia, to ESCC (P<0.05). Furthermore, the expression levels of ADAM29 and FAM135B proteins in ESCC were not associated with age and the tumor size (P>0.05); however, the protein levels were associated with the pathological stage, clinical stage and lymph node metastasis of ESCC (P<0.05). In addition, there was a significant association between the expression levels of ADAM29 protein and FAM135B protein (χ2=60.071; P<0.001). The results of the present study demonstrated that the expression levels of ADAM29 and FAM135B were associated with the tumor behavior characteristics and the progression of esophageal cancer, the expression of which could be used for the diagnosis of early esophageal cancer, and provide the basis for guiding individualized treatment.

View Figures

View References

1	Bray F, Ferlay J, Soerjomataram I, Siegel RL, Torre LA and Jemal A: Global cancer statistics 2018 GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA Cancer J Clin. 68:394–424. 2018. View Article : Google Scholar : PubMed/NCBI
2	Wei KR, Lian QH, Liu J and Liang ZH: Prevalence of esophageal cancer. Chin J Int Med. 51:156–158. 2012.(In Chinese).
3	Malhotra GK, Yanala U, Ravipati A, Follet M, Vijayakumar M and Are C: Global trends in esophageal cancer. J Surg Oncol. 115:564–579. 2017. View Article : Google Scholar : PubMed/NCBI
4	Torre LA, Bray F, Siegel RL, Ferlay J, Lortet-Tieulent J and Jemal A: Global cancer statistics, 2012. CA Cancer J Clin. 65:87–108. 2015. View Article : Google Scholar : PubMed/NCBI
5	Zhang Y: Epidemiology of esophageal cancer. World J Gastroenterol. 19:5598–5606. 2013. View Article : Google Scholar : PubMed/NCBI
6	Zhou MG, Wang XF, Hu JP, Li GL, Chen WQ, Zhang SW, Wan X, Wang LJ, Xiang C, Hu YS and Yang GH: Geographical distribution of cancer mortality in China, 2004–2005. Zhonghua Yu Fang Yi Xue Za Zhi. 44:303–308. 2010.(In Chinese). PubMed/NCBI
7	Li QW, Yuan GJ, Du YX, Pan CN and He Y: Analysis of the prevalence and treatment of esophageal cancer in huai an area. J Clin Oncol. 17:142–145. 2012.
8	Siegel R, Naishadham D and Jemal A: Cancer statistics, 2012. CA Cancer J Clin. 62:10–29. 2012. View Article : Google Scholar : PubMed/NCBI
9	Wang GQ, Jiao GG, Chang FB, Fang WH, Song JX, Lu N, Lin DM, Xie YQ and Yang L: Long-term results of operation for 420 patients with early squamous cell esophageal carcinoma discovered by screening. Ann Thorac Surg. 77:1740–1744. 2004. View Article : Google Scholar : PubMed/NCBI
10	Aminian A, Panahi N, Mirsharifi R, Karimian F, Meysamie A, Khorgami Z and Alibakhshi A: Predictors and outcome of cervical anastomotic leakage after esophageal cancer surgery. J Cancer Res Ther. 7:448–453. 2011. View Article : Google Scholar : PubMed/NCBI
11	Wang GQ, Zhang YM and He S: Present situation and prospect of diagnosis and treatment of early esophageal cancer and precancerous lesions in China. Chin Cancer. 18:690–694. 2009.(In Chinese).
12	Siewert JR and Ott K: Are squamous and adenocarcinomas of the esophagus the same disease. Semin Radiat Oncol. 17:38–44. 2007. View Article : Google Scholar : PubMed/NCBI
13	Hao J and Shao K: Epidemiological status, diagnosis and treatment of esophageal cancer in China and China's future countermeasures. Chin J Cancer. 501–504. 2011.(In Chinese).
14	Song Y, Li L, Ou Y, Gao Z, Li E, Li X, Zhang W, Wang J, Xu L, Zhou Y, et al: Identification of genomic alterations in oesophageal squamous cell cancer. Nature. 509:91–95. 2014. View Article : Google Scholar : PubMed/NCBI
15	Cerretti DP, DuBose RF, Black RA and Nelson N: Isolation of two novel metalloproteinase-disintegrin (ADAM) cDNAs that show testis-specific gene expression. Biochem Biophys Res Commun. 263:810–815. 1999. View Article : Google Scholar : PubMed/NCBI
16	Edwards DR, Handsley MM and Pennington CJ: The ADAM metalloproteinases. Mol Aspects Med. 29:258–289. 2008. View Article : Google Scholar : PubMed/NCBI
17	Wang F, Xu R, Zhu P, Hu J, Ying B, Zhao S and Li C: Preliminarily functional analysis of a cloned novel human gene ADAM29. Sci China C Life Sci. 44:392–399. 2001. View Article : Google Scholar : PubMed/NCBI
18	Oria VO, Lopatta P, Schmitz T, Preca BT, Nyström A, Conrad C, Bartsch JW, Kulemann B, Hoeppner J, Maurer J, et al: ADAM9 contributes to vascular invasion in pancreatic ductal adenocarcinoma. Mol Oncol. 13:456–479. 2019. View Article : Google Scholar : PubMed/NCBI
19	Luo ML, Zhou Z, Sun LC, Sun L, Yu L, Sun L, Liu J, Yang Z, Ran Y, Yao Y and Hu H: An ADAM12 and FAK positive feedback loop amplifies the interaction signal of tumor cells with extracellular matrix to promote esophageal cancer metastasis. Cancer Lett. 422:118–128. 2018. View Article : Google Scholar : PubMed/NCBI
20	Li W, Wang D, Sun X, Zhang Y, Wang L and Suo J: ADAM17 promotes lymph node metastasis in gastric cancer via activation of the Notch and Wnt signaling pathways. Int J Mol Med. 43:914–926. 2019.PubMed/NCBI
21	Mochizuki S and Okada Y: ADAMs in cancer cell proliferation and progression. Cancer Sci. 98:621–628. 2007. View Article : Google Scholar : PubMed/NCBI
22	Zhang B, Li Y, Li L, Chen M, Zhang C, Zuo XB, Zhou FS, Liang B, Zhu J, Li P, et al: Association study of susceptibility loci with specific breast cancer subtypes in Chinese women. Breast Cancer Res Treat. 146:503–514. 2014. View Article : Google Scholar : PubMed/NCBI
23	Shan Q, Lou X, Xiao T, Zhang J, Sun H, Gao Y, Cheng S, Wu L, Xu N and Liu S: A cancer/testis antigen microarray to screen autoantibody biomarkers of non-small cell lung cancer. Cancer Lett. 328:160–167. 2013. View Article : Google Scholar : PubMed/NCBI
24	Costa NR, Paulo P, Caffrey T, Hollingsworth MA and Santos-Silva F: Impact of MUC1 mucin down regulation in the phenotypic characteristics of MKN45 gastric carcinoma cell line. PLoS One. 6:e269702011. View Article : Google Scholar : PubMed/NCBI
25	Brim H, Abu-Asab MS, Nouraie M, Salazar J, Deleo J, Razjouyan H, Mokarram P, Schaffer AA, Naghibhossaini F and Ashktorab H: An integrative CGH, MSI and candidate genes methylation analysis of colorectal tumors. PLoS One. 9:e821852014. View Article : Google Scholar : PubMed/NCBI
26	Wei X, Moncada-Pazos A, Cal S, Soria-Valles C, Gartner J, Rudloff U, Lin JC; NISC Comparative Sequencing Program, ; Rosenberg SA, López-Otín C and Samuels Y: Analysis of the disintegrin-metalloproteinases family reveals ADAM29 and ADAM7 are often mutated in melanoma. Hum Mutat. 32:E2148–E2175. 2011. View Article : Google Scholar : PubMed/NCBI
27	Oki NO, Motsinger-Reif AA, Antas PR, Levy S, Holland SM and Sterling TR: Novel human genetic variants associated with extrapulmonary tuberculosis A pilot genome wide association study. BMC Res Notes. 4:282011. View Article : Google Scholar : PubMed/NCBI
28	Zhou C, Ye M, Ni S, Li Q, Ye D, Li J, Shen Z and Deng H: DNA methylation biomarkers for head and neck squamous cell carcinoma. Epigenetics. 13:398–409. 2018. View Article : Google Scholar : PubMed/NCBI
29	Rice TW: Esophageal cancer staging. Korean J Thorac Cardiovasc Surg. 48:157–163. 2015. View Article : Google Scholar : PubMed/NCBI
30	Rice TW, Rusch VW, Ishwaran H and Blackstone EH; Worldwide Esophageal Cancer Collaboration, : Cancer of the esophagus and esophagogastric junction Data-driven staging for the seventh edition of the American joint committee on cancer/international union against cancer staging manuals. Cancer. 116:3763–3773. 2010. View Article : Google Scholar : PubMed/NCBI
31	Edge SB, Byrd DR, Compton CC, et al: AJCC cancer staging manual. 7th. Springer; New York, NY: 2010
32	Zhou ZJ, Xie JL, Wei P and Zhou XG: Pathologic subtyping of primary lymphoma of breast and prognostic analysis. Zhonghua Bing Li Xue Za Zhi. 46:618–622. 2017.(In Chinese; Abstract available in Chinese from the publisher). PubMed/NCBI
33	Seals DF and Courtneidge SA: The ADAMs family of metalloproteases: Multidomain proteins with multiple functions. Genes Dev. 17:7–30. 2003. View Article : Google Scholar : PubMed/NCBI
34	Rocks N, Paulissen G, El Hour M, Quesada F, Crahay C, Gueders M, Foidart JM, Noel A and Cataldo D: Emerging roles of ADAM and ADAMTS metalloproteinases in cancer. Biochimie. 90:369–379. 2008. View Article : Google Scholar : PubMed/NCBI
35	Noël A, Gutiérrez-Fernández A, Sounni NE, Behrendt N, Maquoi E, Lund IK, Cal S, Hoyer-Hansen G and López-Otín C: New and paradoxical roles of matrix metalloproteinases in the tumor microenvironment. Front Pharmacol. 3:1402012. View Article : Google Scholar : PubMed/NCBI
36	Lu X, Lu D, Scully M and Kakkar V: ADAM proteins-therapeutic potential in cancer. Curr Cancer Drug Targets. 8:720–732. 2008. View Article : Google Scholar : PubMed/NCBI
37	Murphy G: The ADAMs Signalling scissors in the tumour microenvironment. Nat Rev Cancer. 8:929–941. 2008. View Article : Google Scholar : PubMed/NCBI
38	Maloum K, Settegrana C, Chapiro E, Cazin B, Leprêtre S, Delmer A, Leporrier M, Dreyfus B, Tournilhac O, Mahe B, et al: IGHV gene mutational status and LPL/ADAM29 gene expression as clinical outcome predictors in CLL patients in remission following treatment with oral fludarabine plus cyclophosphamide. Ann Hematol. 88:1215–1221. 2009. View Article : Google Scholar : PubMed/NCBI
39	Quilter CR, Sargent CA, Bauer J, Bagga MR, Reiter CP, Hutchinson EL, Southwood OI, Evans G, Mileham A, Griffin DK and Affara NA: An association and haplotype analysis of porcine maternal infanticide A model for human puerperal psychosis. Am J Med Genet B Neuropsychiatr Genet. 159:908–927. 2012. View Article : Google Scholar
40	Tsang KM, Croen LA, Torres AR, Kharrazi M, Delorenze GN, Windham GC, Yoshida CK, Zerbo O and Weiss LA: A genome-wide survey of transgenerational genetic effects in autism. PLoS One. 8:e769782013. View Article : Google Scholar : PubMed/NCBI
41	Lin JQ, Huang ZJ, Chen ZR, et al: Relationship between FAM135B gene and lymph node metastasis of esophageal squamous cell carcinoma. Chin J Exp Surg. 6:1170–1171. 2018.(In Chinese).
42	Dong DZ: The Function and Mechanism of FAM135B in the Deveopment of esophageal squamous cell carcinoma (unpublished PhD thesis). Peking Union Medical College; 2018